We are live on
!
Find out more
Bessemer Group Portfolio holdings
AUM
$63.6B
1-Year Est. Return
28.76%
This Fund
S&P 500
This Quarter
Est. Return
+0.85%
1 Year Est. Return
+28.76%
3 Year Est. Return
+103.2%
5 Year Est. Return
+139.19%
10 Year Est. Return
+508.5%
AUM
$25.7B
AUM Growth
-$62.8M
(-0.24%)
Cap. Flow
-$122M
Cap. Flow
% of AUM
-0.47%
Top 10 Holdings %
Top 10 Hldgs %
18.43%
Holding
1,885
New
196
Increased
495
Reduced
475
Closed
173
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cintas
CTAS
|
+$191M |
| 2 |
Salesforce
CRM
|
+$110M |
| 3 |
Zoetis
ZTS
|
+$105M |
| 4 |
Union Pacific
UNP
|
+$101M |
| 5 |
IBM
IBM
|
+$93.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$252M |
| 2 |
Campbell Soup
CPB
|
+$155M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$116M |
| 4 |
Comcast
CMCSA
|
+$102M |
| 5 |
RTN
Raytheon Company
RTN
|
+$98M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.27% |
| 2 | Technology | 14.3% |
| 3 | Consumer Discretionary | 12.1% |
| 4 | Healthcare | 11.66% |
| 5 | Industrials | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVX
576
DELISTED
AVX Corporation
AVX
| $915K | ﹤0.01% |
55,300
-5,200
| -9% | -$91.8K |
|
577
Carlyle Group
CG
$16.7B
| $913K | ﹤0.01% |
42,789
| – | – |
|
578
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.93B
| $907K | ﹤0.01% |
11,738
| – | – |
|
|
CTLT
579
DELISTED
CATALENT, INC.
CTLT
| $907K | ﹤0.01% |
22,100
+3,700
| +20% | +$157K |
|
580
iShares MSCI ACWI ETF
ACWI
$32.5B
| $906K | ﹤0.01% |
12,640
-90,254
| -88% | -$6.65M |
|
|
VIVO
581
DELISTED
Meridian Bioscience Inc
VIVO
| $906K | ﹤0.01% |
63,800
+44,500
| +231% | +$659K |
|
|
MCHB
582
Mechanics Bancorp
MCHB
$3.49B
| $905K | ﹤0.01% |
31,600
| – | – |
|
583
PVH
PVH
$4B
| $904K | ﹤0.01% |
5,973
-3,329
| -36% | -$485K |
|
584
AngioDynamics
ANGO
$596M
| $897K | ﹤0.01% |
52,000
| – | – |
|
585
CSX Corp
CSX
$95.8B
| $889K | ﹤0.01% |
47,928
+17,601
| +58% | +$329K |
|
586
National Healthcare
NHC
$3.58B
| $888K | ﹤0.01% |
14,900
-22,543
| -60% | -$1.38M |
|
587
Middlesex Water
MSEX
$1.09B
| $883K | ﹤0.01% |
24,045
| – | – |
|
|
SP
588
DELISTED
SP Plus Corporation
SP
| $879K | ﹤0.01% |
24,700
+200
| +0.8% | +$7.49K |
|
589
Strategy Inc
MSTR
$35.6B
| $877K | ﹤0.01% |
68,000
+9,000
| +15% | +$121K |
|
590
New Jersey Resources
NJR
$6.11B
| $868K | ﹤0.01% |
21,633
+16,338
| +309% | +$636K |
|
591
The RMR Group
RMR
$345M
| $867K | ﹤0.01% |
12,400
+112
| +0.9% | +$7.21K |
|
|
CUTR
592
DELISTED
Cutera, Inc.
CUTR
| $864K | ﹤0.01% |
17,200
-2,600
| -13% | -$127K |
|
|
UBA
593
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $859K | ﹤0.01% |
44,500
| – | – |
|
594
Methode Electronics
MEI
$515M
| $848K | ﹤0.01% |
21,700
-11,800
| -35% | -$478K |
|
595
LXP Industrial Trust
LXP
$3.52B
| $847K | ﹤0.01% |
21,520
-13,320
| -38% | -$567K |
|
|
ALX
596
Alexander's
ALX
$1.35B
| $842K | ﹤0.01% |
2,208
-400
| -15% | -$148K |
|
597
Peoples Bancorp
PEBO
$1.5B
| $826K | ﹤0.01% |
23,300
+100
| +0.4% | +$3.49K |
|
|
MTSC
598
DELISTED
MTS Systems Corp
MTSC
| $826K | ﹤0.01% |
16,000
+2,500
| +19% | +$129K |
|
|
LHCG
599
DELISTED
LHC Group LLC
LHCG
| $825K | ﹤0.01% |
13,400
-1,800
| -12% | -$114K |
|
|
WBT
600
DELISTED
Welbilt, Inc.
WBT
| $823K | ﹤0.01% |
42,295
+4,563
| +12% | +$97.4K |
|
Similar funds
Bessemer Group's Q1 2018 Portfolio in Review
As of Q1 2018, Bessemer Group held 1,885 positions worth $25.7B, down 0.24% from $25.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Bessemer Group's Q1 2018 filing shows 196 new, 495 increased, 475 reduced and 173 closed positions. Its largest new stake was Cintas: 4,607,876 shares worth $197M. The largest sale was Eli Lilly, an estimated $252M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Discretionary.
- Bessemer Group's largest Q1 2018 buy was Cintas: 4,607,876 shares worth $197M.
- Bessemer Group added most to Salesforce in Q1 2018, an estimated $110M increase.
- Bessemer Group's biggest Q1 2018 reduction was Eli Lilly, cutting an estimated $252M.
- Bessemer Group fully exited Validus Hold Ltd in Q1 2018, selling an estimated $19.5M.
- Bessemer Group's ten largest holdings make up 18% of its $25.7B portfolio in Q1 2018.
- Bessemer Group opened 196 new positions and closed 173 in Q1 2018.
- Bessemer Group's portfolio value fell 0.24% quarter-over-quarter to $25.7B.
Based on Bessemer Group's 13F filing for Q1 2018, filed 10 May 2018.